US › Healthcare

Bio-Rad Laboratories Inc (BIO-B)

US · Healthcare · Medical Devices

$337.00+8.93%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$592.1M
Revenue YoY
+1.1%
Net profit
$-527.1M
Profit YoY
-923.6%
EPS
$-19.55
Net margin
-89.0%

Key statistics

Market cap
$8.28B
P/E
51.6
Forward P/E
35.0
P/B
1.21
Book value
$255.37
EPS (TTM)
$6.00
52-week high
$337.00
52-week low
$244.54
50-day MA
$300.57
200-day MA
$294.62
Beta
1.08

Shareholding

Insiders
98.23%
Institutions
0.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Bio-Rad Laboratories Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.